Efficacy and Safety of Dahuang Zhechong Pill in Silicosis: A Randomized Controlled Trial

Table 5

The number of participants with abnormal safety outcomes.

	DG (n = 28)			CG (n = 28)
	Baseline	Week 9	ACR (%)	Baseline	Week 9	ACR (%)
RBC	0	0	0	0	0	0
HGB	0	0	0	0	0	0
ALT	0	0	0	0	0	0
AST	0	0	0	0	0	0
BUN	0	0	0	0	0	0
SCr	0	0	0	0	0	0
Myo	6	5	0	8	6	0
CTnI	0	0	0	0	0	0
PT	0	0	0	0	0	0
INR	0	0	0	0	0	0
APTT	0	0	0	0	0	0

ACR = abnormal-changed rate (the rate of that the outcomes changed from normal to abnormal).